These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2010-023021-38||Switch To RItuXimab in MS A phase 2 open label study of Rituximab in MS patients previously treated with self-injectibles using a target based therapy approach||2015-04-30||due-trials|
|Ongoing||2010-024449-65||Will there be lipid changes during dialysis with Citrasate as dialysate compared to conventional dialysis.||not-yet-due|
|Completed, reported early||2013-002378-26||Switch To RItuXimab in MS extension An extension study of STRIX-MS - a phase 2 open label study of Rituximab in MS patients previously treated with self-injectibles using a target based therapy approa...||2018-04-12||not-yet-due|
|Ongoing||2014-001895-72||VIP-VIZA intensive multimodal cardiovascular intervention sub-study||not-yet-due|
|Ongoing||2018-002385-39||Infusion of hypertonic solutions: A risk factor for delirium after cardiac surgery? A randomised double blinded controlled trial.||not-yet-due|